Anthrax Protective Antigen-directed Antibody class drugs
1 result
Anthim (obiltoxaximab)
(obiltoxaximab)Elusys Therapeutics, Inc.
Usage: ANTHIM is indicated for treating inhalational anthrax in adults and pediatric patients, alongside antibacterial drugs. It is also used for prophylaxis when alternative treatments are unavailable, although risks of hypersensitivity must be considered. ANTHIM works by binding to anthrax toxins, not possessing direct antibacterial properties.